Protective effect of antibiotics on mortality risk from acute respiratory infections in Mexican children

V M Cárdenas1, J S Koopman, F J Garrido

  • 1Center for Public Health Research, National Institute of Public Health, Mexico.

Bulletin of the Pan American Health Organization
|January 1, 1992
PubMed

Insights

Acute respiratory infection (ARI) deaths in young children disproportionately affected the poorest communities and occurred at home. Prompt antibiotic treatment significantly reduced mortality risk, supporting primary healthcare strategies.

Area of Science:

  • Pediatrics
  • Public Health
  • Infectious Diseases

Background:

  • Acute respiratory infections (ARI) are a leading cause of mortality in children under five globally.
  • Socioeconomic factors and access to healthcare significantly influence ARI outcomes.
  • Timely and appropriate medical intervention is crucial for managing severe ARI cases.

Purpose of the Study:

  • To investigate the determinants of mortality from acute respiratory infections in young children.
  • To evaluate the association between antibiotic use and ARI-related deaths.
  • To assess the effectiveness of primary healthcare strategies in reducing childhood ARI mortality.

Main Methods:

  • A case-control study was conducted in urban-suburban and rural areas of Mexico.
  • Mortality data for children under five with ARI were compared with controls who recovered from severe ARI.
  • Statistical analysis, including odds ratios and confidence intervals, was used to assess risk factors.

Main Results:

  • ARI deaths were concentrated in impoverished neighborhoods, with a high proportion of infant fatalities occurring at home.
  • Failure to receive antibiotics was strongly associated with increased mortality (odds ratio 28.5).
  • The protective effect of antibiotics was most pronounced when administered early in the illness course.

Conclusions:

  • Socioeconomic status and delayed antibiotic treatment are critical risk factors for childhood ARI mortality.
  • The findings underscore the importance of accessible and timely antibiotic administration.
  • The study supports the implementation of standardized primary healthcare interventions for severe ARI to reduce child mortality.

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...